— Know what they know.
Not Investment Advice
Also trades as: 0I0J.L (LSE) · $vol 0M

CLX NYSE

The Clorox Company
1W: +1.4% 1M: +3.5% 3M: -12.5% YTD: -10.9% 1Y: -22.7% 3Y: -21.5% 5Y: -35.6%
$87.36
+0.60 (+0.69%)
After Hours: $87.27 (-0.09, -0.10%)
Weekly Expected Move ±4.3%
$79 $83 $86 $90 $94
NYSE · Consumer Defensive · Household & Personal Products · Tech Score Buy · Power 61 · $10.5B mcap · 120M float · 2.28% daily turnover · Short 59% of daily vol
Credit Risk of going bust: lower than 58% of companies Debt: 34.5% of company value Bonds: $83.6M held by 175 funds, 62 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $3.05 (down 96%), The Clorox Company would be worth roughly what it owes.
Total debt $5.52B against a stock market value of $10.49B.
Distance to default 5.93 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $3.08B (short-term plus half of long-term), stock volatility 32.1%; Altman Z 2.01. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
46.5 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 23.1%  ·  5Y Avg: 15.1%
Cost Advantage ★
76
Intangibles
38
Switching Cost
26
Network Effect
27
Scale
75
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CLX shows a Weak competitive edge (46.5/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 23.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$80
Low
$92
Avg Target
$105
High
Based on 8 analysts since Aug 3, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 3Hold: 20Sell: 6Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$93.00
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-19 Deutsche Bank Steve Powers $98 $95 -3 +12.0% $84.80
2026-10-16 Barclays — $84 $80 -4 -7.2% $86.20
2026-10-15 UBS — $105 $91 -14 +4.6% $87.00
2026-10-15 Morgan Stanley — $97 $87 -10 -0.4% $87.34
2026-08-04 Deutsche Bank — $94 $98 +4 -3.2% $101.27
2026-08-04 UBS — $96 $105 +9 +4.4% $100.55
2026-08-04 Evercore ISI — $98 $99 +1 -1.7% $100.72
2026-08-04 Barclays Lauren Lieberman $85 $84 -1 -14.5% $98.26
2026-07-28 Jefferies Kaumil Gajrawala $139 $98 -41 +0.6% $97.41
2026-07-23 Evercore ISI Javier Escalante $110 $98 -12 +4.7% $93.61
2026-07-22 Deutsche Bank — $91 $94 +3 -2.3% $96.25
2026-05-01 Morgan Stanley — $125 $97 -28 +9.9% $88.25
2026-05-01 Goldman Sachs Bonnie Herzog $94 $83 -11 -5.4% $87.73
2026-05-01 Evercore ISI Javier Escalante $140 $110 -30 +24.6% $88.30
2026-05-01 Deutsche Bank Steve Powers $114 $91 -23 -5.6% $96.44
2026-05-01 UBS — $121 $96 -25 -0.5% $96.44
2026-05-01 Barclays — $109 $85 -24 -11.9% $96.44
2026-04-21 Jefferies Kaumil Gajrawala $152 $139 -13 +38.5% $100.34
2026-04-09 RBC Capital — $132 $127 -5 +18.0% $107.62
2026-04-08 Wells Fargo — $125 $110 -15 +4.1% $105.67
2026-02-17 Wells Fargo Chris Carey $115 $125 +10 -0.7% $125.94
2026-02-13 Redburn Partners — Initiated $117 — -6.1% $124.64
2026-02-04 UBS Peter Grom $115 $121 +6 +3.1% $117.35
2026-02-04 RBC Capital — $138 $132 -6 +13.2% $116.62
2026-01-23 Deutsche Bank — $151 $114 -37 -1.1% $115.22
2026-01-23 Wells Fargo — $108 $115 +7 +2.5% $112.20
2026-01-16 Barclays — $112 $109 -3 -0.2% $109.26
2026-01-14 UBS Peter Grom $119 $115 -4 +3.9% $110.64
2026-01-07 Goldman Sachs — $132 $94 -38 -6.6% $100.61
2026-01-05 Wells Fargo — $117 $108 -9 +8.4% $99.67
2025-11-04 Morgan Stanley Dara Mohsenian $150 $125 -25 +14.2% $109.42
2025-11-04 UBS Peter Grom $128 $119 -9 +9.0% $109.14
2025-11-04 Wells Fargo — $142 $117 -25 +7.2% $109.14
2025-11-04 Jefferies Kaumil Gajrawala $187 $152 -35 +39.3% $109.14
2025-10-08 UBS — $148 $128 -20 +7.7% $118.81
2025-10-01 Barclays — $119 $112 -7 -8.7% $122.67
2025-07-15 Barclays Lauren Lieberman $129 $119 -10 -6.1% $126.78
2025-05-07 Barclays Lauren Lieberman $139 $129 -10 -4.5% $135.05
2025-05-06 Evercore ISI Javier Escalante Initiated $140 — +3.7% $135.05
2025-05-06 Morgan Stanley Dara Mohsenian $145 $150 +5 +11.1% $135.05
2025-05-06 Wells Fargo Chris Carey $135 $142 +7 +6.3% $133.64
2025-03-27 Barclays Lauren Lieberman $122 $139 +17 -4.6% $145.63
2024-10-08 Goldman Sachs Bonnie Herzog Initiated $132 — -17.3% $159.56
2024-10-01 Jefferies Kaumil Gajrawala $145 $187 +42 +12.8% $165.83
2024-07-19 Barclays Lauren Lieberman $101 $122 +21 -10.5% $136.31
2024-05-02 Wells Fargo Chris Carey $135 $135 0 -3.3% $139.63
2024-03-26 Jefferies Kaumil Gajrawala $145 $145 0 -3.7% $150.52
2024-01-30 RBC Capital Nik Modi Initiated $138 — -5.5% $145.97
2023-10-05 Raymond James Olivia Tong $165 $185 +20 +48.4% $124.69
2023-09-08 J.P. Morgan Ken Goldman $126 $153 +27 -1.4% $155.10

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 27, 2026
DCF
4
ROE
5
ROA
4
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CLX receives an overall rating of B. Strongest factors: DCF (4/5), ROE (5/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-27 B+ B
2026-10-26 B B+
2026-10-23 B+ B
2026-10-22 B B+
2026-10-12 B+ B
2026-10-01 B B+
2026-09-23 B+ B
2026-09-18 B B+
2026-09-11 B+ B
2026-09-04 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 40 Grade C
Profitability
68
Balance Sheet
25
Earnings Quality
82
Growth
41
Value
49
Momentum
45
Safety
50
Cash Flow
34
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CLX scores highest in Earnings Quality (82/100) and lowest in Balance Sheet (25/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.09
Grey Zone
Piotroski F-Score
4/9
✓ ✓ ✗ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
-2.01
Unlikely Manipulator
Ohlson O-Score
-4.71
Bankruptcy prob: 0.9%
Low Risk
Credit Rating
BB
Score: 41.1/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.04x
Accruals: -0.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CLX scores 2.09, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CLX scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CLX's score of -2.01 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CLX's implied 0.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CLX receives an estimated rating of BB (score: 41.1/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CLX's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
18.05x
PEG
-0.68x
P/S
1.57x
P/B
117.74x
P/FCF
28.45x
P/OCF
18.83x
EV/EBITDA
14.47x
EV/Revenue
2.51x
EV/EBIT
18.35x
EV/FCF
41.73x
Earnings Yield
5.09%
FCF Yield
3.52%
Shareholder Yield
7.45%
Graham Number
$8.93
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 18.1x earnings, CLX trades at a reasonable valuation. An earnings yield of 5.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $8.93 per share, 872% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.742
NI / EBT
×
Interest Burden
0.859
EBT / EBIT
×
EBIT Margin
0.137
EBIT / Rev
×
Asset Turnover
1.006
Rev / Assets
×
Equity Multiplier
32.494
Assets / Equity
=
ROE
285.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CLX's ROE of 285.6% is driven by financial leverage (equity multiplier: 32.49x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$185.04
Price/Value
0.51x
Margin of Safety
49.02%
Premium
-49.02%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CLX's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CLX actually compounded EPS at 59.0% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. CLX trades at a -49% premium to its adjusted intrinsic value of $185.04, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 18.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$87.33
Median 1Y
$79.86
5th Pctile
$50.07
95th Pctile
$128.45
Ann. Volatility
27.1%
Analyst Target
$93.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Linda Rendle (CEO)
and Chief Executive Officer (CEO)
$1,344,231 $10,699,895 $14,000,460
Luc Bellet EVP
and Chief Financial Officer (CFO)
$751,923 $6,299,808 $7,666,614
Chris Hyder EVP
and Chief Operating Officer
$713,462 $6,249,743 $7,571,244
Kirsten Marriner EVP
and Chief Administrative Officer
$744,231 $4,899,857 $6,243,658
Angela Hilt EVP
and Chief Legal & External Affairs Officer and Corporate Secretary
$746,538 $4,699,847 $6,029,604

CEO Pay Ratio

121:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $14,000,460
Avg Employee Cost (SGA/emp): $115,870
Employees: 9,200

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
9,200
+21.1% YoY
Revenue / Employee
$730,435
Rev: $6,720,000,000
Profit / Employee
$63,804
NI: $587,000,000
SGA / Employee
$115,870
Avg labor cost proxy
R&D / Employee
$12,609
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 58.9% 33.0% 80.1% 95.6% 1.2% 1.4% 36.7% 38.4% 59.5% 42.8% 5.1% 1.0% 31.0% 76.2% 11.8% 2.5% 41.6% -9.1% -37.8% 2.9% 2.86%
ROA 6.7% 3.8% 7.2% 7.4% 6.5% 7.1% 1.2% 2.5% 1.4% 1.3% 4.1% 4.8% 6.2% 8.0% 12.3% 14.3% 14.3% 13.5% 12.7% 8.8% 8.79%
ROIC 23.6% 18.4% 16.5% 16.2% 16.1% 17.2% 17.3% 20.9% 18.7% 19.4% 21.5% 22.4% 29.4% 27.9% 29.7% 29.9% 27.9% 27.6% 25.6% 23.1% 23.10%
ROCE 17.9% 11.5% 18.2% 16.1% 15.4% 16.3% 6.3% 8.5% 6.7% 6.7% 11.7% 12.0% 16.6% 19.4% 31.1% 32.3% 33.5% 33.2% 33.1% 18.3% 18.34%
Gross Margin 36.8% 32.7% 35.7% 36.5% 35.6% 36.0% 41.8% 42.8% 38.5% 43.2% 42.0% 46.2% 45.9% 43.6% 44.3% 46.5% 41.7% 43.2% 43.2% 41.3% 41.27%
Operating Margin 11.8% 6.6% 12.7% 9.6% 9.6% 8.7% 13.3% 14.2% 4.6% 16.2% 12.0% 16.8% 16.7% 13.8% 14.3% 21.1% 8.4% 14.1% 17.0% 52.5% 52.46%
Net Margin 7.9% 4.1% 8.3% 5.6% 4.9% 5.8% -11.0% 8.7% 1.6% 4.7% -2.8% 11.4% 5.6% 11.4% 11.2% 16.7% 5.6% 9.4% 11.2% 8.4% 8.37%
EBITDA Margin 14.6% 10.1% 15.4% 12.0% 11.3% 12.5% -8.2% 16.0% 8.2% 11.2% 2.3% 18.8% 14.5% 18.7% 20.1% 24.6% 13.0% 17.6% 20.4% 17.8% 17.76%
FCF Margin 8.6% 8.2% 7.9% 7.5% 9.6% 10.2% 11.7% 12.6% 11.3% 10.0% 7.9% 6.8% 9.0% 9.7% 11.4% 10.7% 9.4% 11.5% 5.6% 6.0% 6.03%
OCF Margin 12.9% 12.3% 11.7% 11.1% 13.1% 13.5% 14.8% 15.7% 14.2% 12.9% 10.9% 9.8% 12.0% 12.9% 14.6% 13.8% 12.6% 14.6% 8.5% 9.1% 9.11%
ROE 3Y Avg snapshot only 3.30%
ROE 5Y Avg snapshot only 2.28%
ROA 3Y Avg snapshot only 8.99%
ROIC 3Y Avg snapshot only 16.52%
ROIC Economic snapshot only 23.06%
Cash ROA snapshot only 7.85%
Cash ROIC snapshot only 11.19%
CROIC snapshot only 7.41%
NOPAT Margin snapshot only 18.79%
Pretax Margin snapshot only 11.77%
R&D / Revenue snapshot only 1.73%
SGA / Revenue snapshot only 15.86%
SBC / Revenue snapshot only 0.71%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio 39.43 73.90 31.98 32.37 33.93 34.85 232.29 117.71 169.32 199.97 71.97 55.80 52.53 41.22 24.68 17.35 18.32 15.72 16.29 19.63 18.054
P/S Ratio 2.38 2.58 2.06 2.10 1.95 2.15 2.40 2.37 2.07 2.19 2.40 2.20 2.51 2.63 2.44 1.98 2.14 1.76 1.82 1.71 1.566
P/B Ratio 46.83 58.32 36.62 26.90 42.16 47.23 5729.89 79.72 -393.56 301.84 189.80 47.63 312.57 -459.49 634.39 43.78 -658.76 -94.95 -183.86 128.02 117.743
P/FCF 27.79 31.47 26.02 27.96 20.27 21.03 20.46 18.86 18.34 21.97 30.30 32.35 28.03 27.11 21.38 18.47 22.79 15.26 32.42 28.45 28.449
P/OCF 18.45 21.01 17.56 19.03 14.89 15.94 16.17 15.15 14.56 16.95 22.00 22.48 20.93 20.41 16.68 14.32 16.99 12.06 21.39 18.83 18.827
EV/EBITDA 23.39 33.90 19.85 19.26 19.34 19.95 42.40 34.83 34.91 37.39 28.63 24.90 24.36 22.31 15.70 12.02 13.13 11.38 11.91 14.47 14.468
EV/Revenue 2.80 3.01 2.48 2.52 2.37 2.56 2.79 2.72 2.45 2.57 2.78 2.58 2.86 3.02 2.83 2.36 2.57 2.20 2.31 2.51 2.515
EV/EBIT 31.06 51.68 26.38 25.39 26.18 26.66 83.22 58.93 68.17 71.65 43.35 36.58 32.91 29.01 19.03 14.26 15.75 13.72 14.39 18.35 18.348
EV/FCF 32.66 36.71 31.35 33.41 24.59 25.07 23.78 21.61 21.72 25.78 35.22 37.94 31.93 31.14 24.78 22.03 27.37 19.10 41.10 41.73 41.726
Earnings Yield 2.5% 1.4% 3.1% 3.1% 2.9% 2.9% 0.4% 0.8% 0.6% 0.5% 1.4% 1.8% 1.9% 2.4% 4.1% 5.8% 5.5% 6.4% 6.1% 5.1% 5.09%
FCF Yield 3.6% 3.2% 3.8% 3.6% 4.9% 4.8% 4.9% 5.3% 5.5% 4.6% 3.3% 3.1% 3.6% 3.7% 4.7% 5.4% 4.4% 6.6% 3.1% 3.5% 3.52%
EV/OCF snapshot only 27.613
EV/Gross Profit snapshot only 5.942
Acquirers Multiple snapshot only 10.168
Shareholder Yield snapshot only 7.45%
Graham Number snapshot only $8.93
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 0.69 0.67 0.71 0.97 0.88 0.86 0.87 0.95 0.86 0.89 0.90 1.03 1.00 0.94 0.74 0.84 0.76 0.74 0.84 0.66 0.658
Quick Ratio 0.39 0.36 0.40 0.54 0.50 0.47 0.51 0.59 0.54 0.57 0.53 0.63 0.62 0.60 0.44 0.57 0.50 0.48 0.65 0.38 0.378
Debt/Equity 8.78 10.31 8.11 5.58 9.84 9.60 1008.33 13.29 -86.57 59.04 33.19 8.85 48.07 -75.41 109.04 8.97 -139.91 -25.74 -66.96 61.33 61.333
Net Debt/Equity 8.21 9.70 7.50 5.25 8.99 9.08 927.67 11.62 — 52.34 30.78 8.23 43.43 — 100.67 8.45 — — — 59.74 59.744
Debt/Assets 0.51 0.52 0.51 0.50 0.52 0.51 0.52 0.49 0.53 0.53 0.52 0.50 0.52 0.55 0.53 0.52 0.56 0.57 0.70 0.71 0.708
Debt/EBITDA 3.73 5.14 3.65 3.34 3.72 3.40 6.42 5.07 6.48 6.23 4.31 3.94 3.29 3.19 2.33 2.06 2.32 2.46 3.42 4.73 4.726
Net Debt/EBITDA 3.49 4.83 3.38 3.15 3.40 3.22 5.91 4.43 5.44 5.53 4.00 3.67 2.97 2.89 2.15 1.94 2.20 2.29 2.52 4.60 4.604
Interest Coverage 7.01 4.48 7.43 7.26 6.43 6.58 2.18 3.31 2.48 2.50 4.50 4.86 6.30 7.54 10.43 12.00 11.39 11.16 11.19 7.08 7.085
Equity Multiplier 17.05 19.78 15.80 11.08 18.87 18.83 1939.33 27.02 -161.92 111.47 63.79 17.53 91.62 -136.02 204.15 17.32 -251.27 -44.90 -96.06 86.60 86.600
Cash Ratio snapshot only 0.052
Debt Service Coverage snapshot only 8.985
Cash to Debt snapshot only 0.026
FCF to Debt snapshot only 0.073
Defensive Interval snapshot only 288.4 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 1.11 1.09 1.11 1.14 1.13 1.15 1.18 1.22 1.16 1.22 1.24 1.21 1.30 1.25 1.24 1.26 1.23 1.21 1.13 1.01 1.006
Inventory Turnover 6.49 6.19 6.13 6.08 5.93 5.80 5.82 6.19 5.76 6.09 5.95 6.09 6.38 6.39 5.89 6.72 6.45 6.29 6.21 5.96 5.963
Receivables Turnover 10.80 11.95 10.91 11.06 11.12 12.09 10.72 10.79 11.79 11.43 10.67 10.53 12.70 11.18 11.05 9.70 10.43 10.61 10.66 8.42 8.421
Payables Turnover 2.88 3.03 3.03 4.85 5.77 5.88 2.72 4.53 5.03 5.16 2.48 4.12 2.64 2.56 2.10 4.36 2.22 2.21 2.17 3.18 3.180
DSO 34 31 33 33 33 30 34 34 31 32 34 35 29 33 33 38 35 34 34 43 43.3 days
DIO 56 59 60 60 62 63 63 59 63 60 61 60 57 57 62 54 57 58 59 61 61.2 days
DPO 127 121 121 75 63 62 134 81 73 71 147 89 138 142 174 84 164 165 168 115 114.8 days
Cash Conversion Cycle -37 -31 -28 18 31 31 -38 12 22 21 -51 6 -52 -53 -79 8 -73 -73 -75 -10 -10.2 days
Fixed Asset Turnover snapshot only 3.513
Operating Cycle snapshot only 104.6 days
Cash Velocity snapshot only 46.993
Capital Intensity snapshot only 1.160
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 1.4% -5.9% -5.5% -3.2% -2.6% -0.2% 0.9% 4.0% -0.1% 3.5% 0.5% -4.0% 6.2% -2.0% -2.6% 0.2% -9.3% -5.7% -3.7% -5.4% -5.41%
Net Income -62.0% -79.8% -50.4% -34.9% -7.3% 76.1% -83.8% -67.7% -78.8% -81.6% 2.2% 87.9% 3.2% 4.7% 1.9% 1.9% 1.2% 65.2% 8.9% -27.5% -27.53%
EPS -60.6% -79.1% -49.7% -34.1% -7.2% 76.0% -83.8% -68.0% -78.9% -81.7% 2.2% 87.3% 3.2% 4.7% 1.9% 1.9% 1.2% 68.9% 11.0% -26.6% -26.57%
FCF -55.4% -58.1% -56.9% -43.4% 9.4% 24.3% 49.2% 73.8% 17.1% 1.0% -32.1% -48.1% -15.7% -4.5% 40.5% 57.6% -4.9% 11.9% -52.6% -46.8% -46.78%
EBITDA -50.0% -65.8% -40.4% -22.9% -0.5% 44.3% -47.0% -37.8% -42.7% -44.6% 48.8% 27.6% 77.5% 93.2% 80.3% 89.5% 51.2% 34.6% 3.7% -16.3% -16.27%
Op. Income -31.5% -50.2% -54.1% -42.3% -32.2% -6.9% 6.9% 17.9% 10.9% 28.8% 19.6% 7.8% 53.2% 15.1% 22.0% 28.4% -12.5% -4.9% -2.4% 40.1% 40.13%
OCF Growth snapshot only -37.61%
Asset Growth snapshot only 40.15%
Equity Growth snapshot only -71.96%
Debt Growth snapshot only 91.67%
Shares Change snapshot only -1.30%
Dividend Growth snapshot only 1.32%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y 5.3% 4.3% 4.2% 4.6% 4.6% 4.8% 4.1% 3.2% -0.5% -1.0% -1.4% -1.1% 1.1% 0.4% -0.4% -0.0% -1.3% -1.5% -1.9% -3.1% -3.11%
Revenue 5Y 4.5% 3.8% 3.7% 3.5% 3.1% 3.2% 3.4% 3.8% 2.6% 3.2% 2.8% 2.7% 3.9% 3.2% 2.0% 1.1% -1.0% -2.1% -2.1% -1.8% -1.75%
EPS 3Y -18.3% -31.0% -15.4% -16.4% -20.0% -18.3% -55.6% -45.3% -57.4% -59.4% -35.9% -26.6% -6.7% 22.5% 14.8% 20.6% 25.3% 20.9% 1.2% 59.0% 59.01%
EPS 5Y -6.6% -16.8% -6.1% -6.8% -9.7% -10.4% -37.2% -28.1% -36.1% -36.2% -20.6% -18.9% -14.8% -10.6% -3.9% -2.2% -6.4% -8.3% -3.3% -3.2% -3.23%
Net Income 3Y -19.6% -32.1% -16.8% -17.4% -20.7% -18.9% -56.0% -45.9% -57.9% -59.7% -36.2% -26.7% -6.5% 22.8% 14.9% 20.6% 25.0% 20.2% 1.2% 57.9% 57.94%
Net Income 5Y -7.8% -17.7% -7.2% -8.0% -10.7% -11.4% -38.0% -29.0% -36.6% -36.7% -21.3% -19.3% -15.2% -10.9% -4.4% -2.9% -7.2% -9.2% -3.9% -3.7% -3.73%
EBITDA 3Y -12.6% -21.6% -12.1% -10.6% -12.5% -11.3% -29.7% -26.6% -34.2% -35.1% -22.2% -15.1% 0.4% 15.6% 12.4% 14.6% 15.4% 13.0% 40.7% 26.5% 26.50%
EBITDA 5Y -6.8% -12.6% -6.4% -6.2% -7.8% -6.8% -18.2% -15.0% -17.5% -17.3% -11.7% -10.7% -7.4% -5.7% -1.4% -0.9% -5.2% -6.6% -2.5% -0.6% -0.59%
Gross Profit 3Y 3.3% -0.6% -2.5% -2.6% -3.0% -2.1% -2.1% -1.8% -5.4% -4.6% -4.5% -1.8% 3.9% 6.1% 7.6% 8.3% 6.5% 5.5% 3.2% -0.7% -0.66%
Gross Profit 5Y 2.4% 0.1% -0.9% -1.2% -1.8% -1.1% 0.1% 1.6% 1.0% 2.4% 2.0% 2.1% 4.0% 3.3% 2.0% 0.9% -2.1% -3.3% -3.1% -2.4% -2.36%
Op. Income 3Y -3.7% -12.2% -15.2% -13.5% -15.3% -13.6% -14.6% -12.5% -19.9% -15.8% -16.3% -9.8% 4.8% 11.4% 16.0% 17.7% 14.1% 12.1% 12.5% 24.7% 24.70%
Op. Income 5Y -1.0% -6.5% -8.2% -8.5% -10.0% -8.5% -8.0% -5.5% -7.6% -4.1% -4.9% -3.8% 0.6% -0.9% -1.9% -1.5% -7.1% -8.1% -6.9% 5.7% 5.68%
FCF 3Y -7.9% -13.9% -11.1% -12.0% -4.6% -3.8% -4.6% -10.4% -17.0% -19.3% -24.1% -20.0% 2.6% 6.2% 12.5% 12.5% -2.1% 2.6% -23.2% -24.2% -24.20%
FCF 5Y 0.7% -2.0% -1.0% -3.4% -1.6% 0.1% 1.9% 3.6% 0.0% -4.4% -6.6% -9.3% -3.0% -3.0% -3.7% -10.0% -14.5% -10.9% -21.9% -15.6% -15.59%
OCF 3Y -1.4% -7.6% -6.0% -7.5% -2.8% -3.0% -3.8% -9.2% -15.5% -17.4% -21.7% -18.3% -1.4% 2.0% 7.2% 7.7% -2.6% 1.1% -18.5% -19.1% -19.15%
OCF 5Y 3.1% 0.1% 0.5% -2.0% -0.7% 0.7% 2.1% 3.5% 0.5% -3.0% -4.8% -6.9% -2.3% -2.4% -3.0% -8.7% -12.4% -10.1% -18.8% -13.7% -13.67%
Assets 3Y 7.4% 6.9% 7.0% 6.4% 4.5% 3.5% -0.2% -1.5% -4.0% -4.8% -3.4% -3.2% -4.3% -3.4% -4.5% -3.3% -3.5% -2.4% 3.4% 9.4% 9.45%
Assets 5Y 7.0% 6.3% 6.4% 6.1% 6.0% 4.9% 1.3% 3.3% 3.4% 3.1% 2.4% 2.4% 0.4% 0.4% -1.2% -2.2% -4.0% -3.9% -0.0% 4.2% 4.24%
Equity 3Y -18.4% -25.0% -20.0% -0.2% -16.0% -16.7% -83.7% -37.7% — -64.5% -50.3% -7.2% -45.4% — -59.3% -16.7% — — — -25.8% -25.77%
Book Value 3Y -17.1% -23.8% -18.6% 1.0% -15.2% -16.0% -83.6% -37.0% — -64.2% -50.2% -7.2% -45.5% — -59.3% -16.7% — — — -25.3% -25.26%
Dividend 3Y 2.8% 2.6% 2.4% 2.0% 1.8% 1.6% 1.8% 1.7% 1.8% 1.7% 1.1% 0.8% 0.4% 0.3% 0.5% 0.4% 0.5% 0.7% 0.6% 0.7% 0.68%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.83 0.67 0.74 0.85 0.73 0.55 0.64 0.85 0.53 0.44 0.41 0.51 0.73 0.75 0.57 0.37 0.03 0.67 0.92 0.72 0.725
Earnings Stability 0.00 0.02 0.04 0.22 0.22 0.23 0.57 0.72 0.64 0.51 0.72 0.82 0.60 0.42 0.26 0.15 0.11 0.07 0.00 0.01 0.014
Margin Stability 0.95 0.92 0.90 0.90 0.89 0.89 0.89 0.90 0.90 0.89 0.90 0.91 0.91 0.91 0.90 0.90 0.89 0.90 0.92 0.95 0.949
Rev. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.50 1.00 0.00 0.50 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.86 0.97 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.96 0.89 0.890
Earnings Smoothness 0.10 0.00 0.33 0.58 0.92 0.45 0.00 0.00 0.00 0.00 0.00 0.39 0.00 0.00 0.03 0.03 0.24 0.51 0.91 0.68 0.681
ROE Trend -0.07 -0.46 -0.10 -0.55 0.13 0.44 23.47 -0.60 — 0.44 -10.27 0.10 — — 12.05 1.76 — — — 4.83 4.834
Gross Margin Trend -0.05 -0.08 -0.10 -0.09 -0.09 -0.06 -0.03 -0.00 0.02 0.05 0.05 0.05 0.07 0.06 0.05 0.04 0.02 0.01 0.00 -0.02 -0.016
FCF Margin Trend -0.07 -0.08 -0.08 -0.09 -0.04 -0.03 -0.01 0.02 0.02 0.01 -0.02 -0.03 -0.02 -0.00 0.02 0.01 -0.01 0.02 -0.04 -0.03 -0.027
Sustainable Growth Rate -16.6% -42.2% -18.9% -22.5% -48.7% -44.8% -2.5% -1.1% -3.5% -2.7% -7.5% -1.1% -20.9% -23.7% 1.6% 64.1% 9.9% — — -7.3% -7.30%
Internal Growth Rate — — — — — — — — — — — — — — 1.7% 3.8% 3.6% 2.8% 2.6% — —
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 2.14 3.52 1.82 1.70 2.28 2.19 14.36 7.77 11.63 11.80 3.27 2.48 2.51 2.02 1.48 1.21 1.08 1.30 0.76 1.04 1.043
FCF/OCF 0.66 0.67 0.68 0.68 0.73 0.76 0.79 0.80 0.79 0.77 0.73 0.69 0.75 0.75 0.78 0.78 0.75 0.79 0.66 0.66 0.662
FCF/Net Income snapshot only 0.690
OCF/EBITDA snapshot only 0.524
CapEx/Revenue 4.3% 4.1% 3.8% 3.5% 3.5% 3.3% 3.1% 3.1% 2.9% 3.0% 3.0% 3.0% 3.0% 3.2% 3.2% 3.1% 3.2% 3.0% 2.9% 3.1% 3.08%
CapEx/Depreciation snapshot only 0.838
Accruals Ratio -0.08 -0.10 -0.06 -0.05 -0.08 -0.08 -0.16 -0.17 -0.15 -0.14 -0.09 -0.07 -0.09 -0.08 -0.06 -0.03 -0.01 -0.04 0.03 -0.00 -0.004
Sloan Accruals snapshot only -0.133
Cash Flow Adequacy snapshot only 0.756
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield 3.2% 3.1% 3.9% 3.8% 4.2% 3.8% 3.4% 3.3% 4.0% 3.7% 3.4% 3.8% 3.2% 3.2% 3.5% 4.3% 4.2% 5.1% 4.9% 5.2% 5.71%
Dividend/Share $4.51 $4.54 $4.57 $4.61 $4.63 $4.65 $4.69 $4.68 $4.71 $4.73 $4.76 $4.76 $4.79 $4.80 $4.84 $4.86 $4.89 $4.94 $4.94 $4.93 $4.97
Payout Ratio 1.3% 2.3% 1.2% 1.2% 1.4% 1.3% 7.8% 3.9% 6.8% 7.4% 2.5% 2.1% 1.7% 1.3% 86.6% 74.3% 76.1% 79.7% 79.6% 1.0% 1.03%
FCF Payout Ratio 90.3% 97.1% 1.0% 1.1% 84.7% 80.0% 69.0% 62.7% 73.9% 81.0% 1.0% 1.2% 89.2% 86.2% 75.0% 79.1% 94.7% 77.4% 1.6% 1.5% 1.49%
Total Payout Ratio 3.2% 4.8% 1.9% 1.3% 1.4% 1.3% 7.8% 3.9% 6.8% 7.4% 2.5% 2.1% 2.0% 1.9% 1.2% 1.2% 1.2% 1.2% 1.2% 1.5% 1.46%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0
Chowder Number 0.07 0.06 0.06 0.06 0.07 0.06 0.06 0.05 0.06 0.06 0.05 0.06 0.05 0.05 0.05 0.05 0.05 0.06 0.05 0.05 0.052
Buyback Yield 4.8% 3.5% 2.2% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 1.4% 1.5% 2.4% 2.4% 2.8% 2.7% 2.2% 2.22%
Net Buyback Yield 4.2% 3.3% 2.2% 0.1% -0.1% -0.1% -0.1% -0.2% -0.3% -0.2% -0.2% -0.0% 0.5% 1.2% 1.3% 2.2% 2.4% 2.6% 2.5% 2.0% 2.02%
Total Shareholder Return 7.5% 6.4% 6.1% 4.0% 4.1% 3.7% 3.3% 3.1% 3.8% 3.5% 3.3% 3.8% 3.7% 4.4% 4.8% 6.5% 6.5% 7.7% 7.4% 7.2% 7.25%
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.78 0.77 0.79 0.76 0.75 0.76 0.57 0.63 0.57 0.51 0.67 0.70 0.65 0.71 0.74 0.75 0.78 0.77 0.77 0.74 0.742
Interest Burden (EBT/EBIT) 0.86 0.78 0.87 0.86 0.84 0.85 0.54 0.70 0.60 0.60 0.78 0.79 0.84 0.87 0.90 0.92 0.91 0.91 0.91 0.86 0.859
EBIT Margin 0.09 0.06 0.09 0.10 0.09 0.10 0.03 0.05 0.04 0.04 0.06 0.07 0.09 0.10 0.15 0.17 0.16 0.16 0.16 0.14 0.137
Asset Turnover 1.11 1.09 1.11 1.14 1.13 1.15 1.18 1.22 1.16 1.22 1.24 1.21 1.30 1.25 1.24 1.26 1.23 1.21 1.13 1.01 1.006
Equity Multiplier 8.80 8.71 11.17 12.92 17.91 19.30 30.12 15.60 42.02 31.96 123.65 21.34 499.48 957.08 95.91 17.43 290.13 -67.41 -298.70 32.49 32.494
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $3.52 $1.99 $3.70 $3.73 $3.27 $3.51 $0.60 $1.20 $0.69 $0.64 $1.93 $2.24 $2.86 $3.67 $5.59 $6.55 $6.43 $6.19 $6.21 $4.81 $4.81
Book Value/Share $2.97 $2.53 $3.23 $4.49 $2.63 $2.59 $0.02 $1.77 $-0.30 $0.43 $0.73 $2.62 $0.48 $-0.33 $0.22 $2.59 $-0.18 $-1.03 $-0.55 $0.74 $2.07
Tangible Book/Share $-16.99 $-17.37 $-16.68 $-15.23 $-16.91 $-16.94 $-15.92 $-13.99 $-15.93 $-15.22 $-14.70 $-12.64 $-14.07 $-14.71 $-14.22 $-11.91 $-14.71 $-11.57 $-11.04 $-20.15 $-20.15
Revenue/Share $58.29 $57.14 $57.38 $57.41 $56.82 $56.98 $57.99 $59.28 $56.44 $58.66 $58.02 $56.72 $59.91 $57.48 $56.57 $57.41 $55.04 $55.43 $55.51 $55.02 $55.18
FCF/Share $5.00 $4.68 $4.54 $4.32 $5.47 $5.82 $6.79 $7.46 $6.37 $5.84 $4.59 $3.86 $5.37 $5.58 $6.46 $6.15 $5.17 $6.38 $3.12 $3.32 $3.33
OCF/Share $7.53 $7.01 $6.73 $6.35 $7.45 $7.67 $8.60 $9.29 $8.02 $7.58 $6.32 $5.56 $7.19 $7.40 $8.28 $7.93 $6.93 $8.07 $4.73 $5.01 $5.03
Cash/Share $1.69 $1.55 $1.95 $1.48 $2.24 $1.35 $1.96 $2.94 $4.16 $2.85 $1.76 $1.62 $2.23 $2.33 $1.82 $1.35 $1.35 $1.86 $9.75 $1.17 $1.17
EBITDA/Share $6.98 $5.07 $7.18 $7.50 $6.96 $7.31 $3.81 $4.63 $3.96 $4.03 $5.64 $5.89 $7.03 $7.78 $10.19 $11.27 $10.78 $10.71 $10.76 $9.56 $9.56
Debt/Share $26.04 $26.05 $26.18 $25.07 $25.90 $24.87 $24.46 $23.46 $25.70 $25.11 $24.31 $23.21 $23.13 $24.80 $23.73 $23.27 $25.02 $26.39 $36.83 $45.20 $45.20
Net Debt/Share $24.35 $24.50 $24.23 $23.59 $23.65 $23.51 $22.51 $20.51 $21.54 $22.26 $22.54 $21.60 $20.90 $22.48 $21.91 $21.92 $23.67 $24.53 $27.09 $44.03 $44.03
Per Employee
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Employee Count snapshot only 9,200
Revenue/Employee snapshot only $730434.78
Income/Employee snapshot only $63804.35
EBITDA/Employee snapshot only $126956.52
FCF/Employee snapshot only $44021.74
Assets/Employee snapshot only $847173.91
Market Cap/Employee snapshot only $1252384.01
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.092
Altman Z-Prime snapshot only 1.761
Piotroski F-Score 5 4 4 5 5 8 7 6 5 6 7 6 8 7 6 7 5 5 5 4 4
Beneish M-Score -2.78 -2.85 -2.61 -2.60 -2.94 -2.90 -3.43 -3.39 -3.34 -3.18 -2.92 -2.84 -2.95 -3.00 -2.92 -2.46 -2.26 -2.57 -2.23 -2.01 -2.015
Ohlson O-Score snapshot only -4.710
Net-Net WC snapshot only $-46.82
EVA snapshot only $716083817.95
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only BB
Credit Score 57.94 49.28 58.68 62.03 57.63 55.27 42.40 54.58 20.00 42.40 46.31 49.01 55.65 58.31 60.49 64.49 59.96 59.68 53.60 41.14 41.144
Credit Grade snapshot only 12
Credit Trend snapshot only -23.342
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 27
Sector Credit Rank snapshot only 29

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms